Increased insulin dose requirement of long-acting insulin analogues in obese patients with type 2 diabetes

Diabetologia

Volumn 52, Issue 12, 2009, Pages 2668-2669

  Schmid, C ^a   Krayenbuhl P ^a   Wiesli, P ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Kantonsspital Frauenfeld   (Switzerland)

Author keywords

Hyperinsulinaemia; Insulin dose requirement; Long acting insulin analogues; Obesity; Type 2 diabetes

Indexed keywords

INSULIN DETEMIR; INSULIN GLARGINE; ISOPHANE INSULIN; LONG ACTING INSULIN;

BEDTIME DOSAGE; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; GLYCEMIC CONTROL; HUMAN; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL;

AMINO ACID SUBSTITUTION; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, NPH; OBESITY;

EID: 70949095710     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1534-1     Document Type: Letter

References (6)

1. U Smith EAM Gale 2009 Does diabetes therapy influence the risk of cancer? Diabetologia 52 1699 1708 10.1007/s00125-009-1441-5 1:STN:280: DC%2BD1Mrktl2mtQ%3D%3D 19597799
2. P Wiesli P Krayenbühl H Uthoff B Seifert C Schmid 2009 Omitting breakfast and lunch after injection of different long-acting insulin preparations at bedtime: a prospective study in patients with type 2 diabetes Diabetologia 52 1816 1819 10.1007/s00125-009-1439-z 1:STN:280: DC%2BD1MrktlKhug%3D%3D 19565212
3. MC Riddle J Rosenstock J Gerich 2003 The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients Diabetes Care 26 3080 3086 10.2337/diacare.26.11.3080 1:CAS:528:DC%2BD3sXpsFert70%3D 14578243 (Pubitemid 37339502)
4. K Hermansen M Davies T Derezinksi G Martinez Ravn P Clauson P Home 2006 A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes Diabetes Care 29 1269 1274 10.2337/dc05-1365 1:CAS:528:DC%2BD28XmtFKlsr4%3D 16732007 (Pubitemid 44125921)
5. C Fajardo Montañana C Hernández Herrero M Rivas Fernández 2008 Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight type 2 diabetes patients: the PREDICTIVE BMI clinical trial Diabet Med 25 916 923 10.1111/j.1464-5491.2008.02483.x 18959604
6. H Yki-Järvinen R Kauppinen-Mäkelin M Tiikkainen, et al.. 2006 Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study Diabetologia 49 442 451 10.1007/s00125-005-0132-0 16456680 (Pubitemid 43277866)